Comparison of two different strategies for human monocyte subsets gating within the large-scale prospective CARE FOR HOMe Study

Cytometry Part A

Volumn 87, Issue 8, 2015, Pages 750-758

  Zawada, Adam M ^a   Fell, Lisa H ^a   Untersteller, Kathrin ^a   Seiler, Sarah ^a   Rogacev, Kyrill S ^a   Fliser, Danilo ^a   Ziegler Heitbrock, Loems ^b   Heine, Gunnar H ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cardiovascular disease; cd14; cd16; Chronic kidney disease; Gating strategy; Monocytes

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; FC RECEPTOR;

AGED; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY;

AGED; ANTIGENS, CD14; BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; RECEPTORS, IGG; RENAL INSUFFICIENCY, CHRONIC;

EID: 84937814187     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22703     Document Type: Article

References (26)

1. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989;74:2527-2534.
2. Belge kU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, Espevik T, Ziegler-Heitbrock L. The proinflammatory cd14+cd16+DR++ monocytes are a major source of TNF. J Immunol 2002;168:3536-3542.
3. Szaflarska A, Baj-Krzyworzeka M, Siedlar M, Weglarczyk K, Ruggiero I, Hajto B, Zembala M. Antitumor response of cd14+/cd16+ monocyte subpopulation. Exp Hematol 2004;32:748-755.
4. Zawada AM, Rogacev KS, Schirmer SH, Sester M, Bohm M, Fliser D, Heine GH. Monocyte heterogeneity in human cardiovascular disease. Immunobiology 2012;217:1273-1284.
5. Ziegler-Heitbrock L. The cd14+ cd16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81:584-592.
6. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW, Gabuzda D. Fractalkine preferentially mediates arrest and migration of cd16+ monocytes. J Exp Med 2003;197:1701-1707.
7. Grage-Griebenow E, Zawatzky R, Kahlert H, Brade L, Flad H, Ernst M. Identification of a novel dendritic cell-like subset of cd64(+)/cd16(+) blood monocytes. Eur J Immunol 2001;31:48-56.
8. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010;116:e74-e80.
9. Rogacev KS, Zawada AM, Hundsdorfer J, Achenbach M, Held G, Fliser D, Heine GH. Immunosuppression and monocyte subsets. Nephrol Dial Transplant 2015;30:143-153.
10. Qu C, Edwards EW, Tacke F, Angeli V, Llodra J, Sanchez-Schmitz G, Garin A, Haque NS, Peters W, van Rooijen N, et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med 2004;200:1231-1241.
11. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH. SuperSAGE evidence for cd14++cd16+ monocytes as a third monocyte subset. Blood 2011;118:e50-e61.
12. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010;33:375-386.
13. Heine GH, Ulrich C, Seibert E, Seiler S, Marell J, Reichart B, Krause M, Schlitt A, Kohler H, Girndt M. Cd14(++)cd16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 2008;73:622-629.
14. Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH. Cd14++cd16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J 2011;32:84-92.
15. Rogacev KS, Zawada AM, Emrich I, Seiler S, Bohm M, Fliser D, Woollard KJ, Heine GH. Lower apo a-I and lower HDL-C levels are associated with higher intermediate cd14++cd16+ monocyte counts that predict cardiovascular events in chronic kidney disease. Arterioscler Thromb Vasc Biol 2014;34:2120-2127.
16. Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Grosse-Dunker G, Heisel I, Hornof F, Jeken J, et al. CD14++CD16+ monocytes independently predict cardiovascular events: A cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 2012;60:1512-1520.
17. Ziegler-Heitbrock L, Hofer TP. Toward a refined definition of monocyte subsets. Front Immunol 2013;4:23
18. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr., Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172.
19. Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: Where are we now?. J Am Coll Cardiol 2013;62:1541-1551.
20. Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost 2011;106:757-762.
21. Berg KE, Ljungcrantz I, Andersson L, Bryngelsson C, Hedblad B, Fredrikson GN Nilsson J, Bjorkbacka H. Elevated cd14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet 2012;5:122-131.
22. Heimbeck I, Hofer TP, Eder C, Wright AK, Frankenberger M, Marei A, Boghdadi G, Scherberich J, Ziegler-Heitbrock L. Standardized single-platform assay for human monocyte subpopulations: Lower cd14+cd16++ monocytes in females. Cytometry Part A 2010;77A:823-830.
23. Ferrer DG, Jaldin-Fincati JR, Amigone JL, Capra RH, Collino CJ, Albertini RA, Chiabrando GA. Standardized flow cytometry assay for identification of human monocytic heterogeneity and lrp1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes. Cytometry Part A 2014;85A:601-610.
24. Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, Kourilsky P, Wong SC. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011;118:e16-31.
25. Combadière C1, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008;117:1649-1657.
26. Wrigley BJ, Shantsila E, Tapp LD, Lip GY. Cd14++cd16+ monocytes in patients with acute ischaemic heart failure. Eur J Clin Invest 2013;43:121-130.